PALO ALTO, Calif., July 12 /PRNewswire/ -- The Technical Insights - Healthcare Group at Frost & Sullivan is pleased to announce its Exclusive Technical Insights Healthcare 2006 Quarterly Analyst Briefing Presentation on the HIV therapeutics market to be held on Tuesday, July 18, 2006 at 11:00 a.m. EDT or 4 p.m. SGT for the Asia Pacific region.
There has been a steady increase in the number of registered cases of HIV infection and its progression into AIDS. Novel strategies are being developed that could involve an array of interventions that either mimic the natural defense mechanisms of the host or are capable of disrupting the adaptive mechanism of the virus. Preventive measures hold a promise for the future like that of the vaccines and microbicides that would eventually be highly effective in preventing the spread of HIV. Different classes of drugs are crucial in curtailing the spread of the disease, but resistance is an issue that is now commonly encountered.
Highlights of the briefing include: an analysis of the technological advancements in drugs for the treatment of HIV and about the employment of preventive measures such as microbicides and vaccines collision trends, crash part market sizing, repair shop trends related to repair jobs, as well as component and chemical purchasing.
This briefing will benefit the drug, vaccine and microbicide manufacturers, distributors, venture capitalists, researchers and clinicians’ biotech and pharmaceutical companies discussing emerging trends and providing forward projections for the HIV therapeutics technologies.
“With a lot of activity in the drugs sector, this market faces the big challenge of resistance,” observes Frost & Sullivan Research Analyst Nivedithaa Gopaalakrishnan. “The industry is preparing itself to treat the affected population through drugs and also bring about the awareness of the lethality and the modes of transmission of the disease. The result has been the developments in the preventive measures arena such as vaccines and microbicides.”
To participate, please email Melina Trevino at melina.trevino@frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, country and the time at which you would like to attend. Upon receipt of the above information, a registration link will be emailed to you.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com .
Contact: Melina Trevino North America Corporate Communications, Healthcare P: 210.247.2403 F: 210.348.1003 E: melina.trevino@frost.comhttp://www.frost.com
Frost & Sullivan
CONTACT: Melina Trevino, North America Corporate Communications,Healthcare of Frost & Sullivan, +1-210-247-2403, or fax, +1-210-348-1003,or melina.trevino@frost.com
Web site: http://www.frost.com/
